WST — West Pharmaceutical Services Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for West Pharmaceutical Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,832	2,887	2,950	2,893	3,074
Cost of Revenue
Gross Profit	1,178	1,136	1,129	999	1,104
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,081	2,205	2,270	2,323	2,489
Operating Profit	751	682	680	570	585
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	749	680	698	586	601
Provision for Income Taxes
Net Income After Taxes	640	560	576	478	479
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	662	586	593	493	494
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	662	586	593	493	494
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	8.75	8.4	8.15	6.82	7.32
Dividends per Share